{"id":"W137786602","doi":"10.1182/blood.v124.21.5567.5567","title":"Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Tolerability; Adverse effect; Internal medicine; Discontinuation; Placebo; Phases of clinical research; Anemia; Surgery; Clinical trial; Gastroenterology; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002964745,0.0005067074,0.0009603872,0.0002864512,0.0003599399,0.0008231924,0.0003628778,0.0007307471,0.00178075],"category_scores_gemma":[0.002366983,0.0002378824,0.0008122292,0.0003003625,0.0003222328,0.0007378099,0.0003476015,0.0012587,0.0003206882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004228298,"about_ca_system_score_gemma":0.0004704294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004041544,"about_ca_topic_score_gemma":0.0006385749,"domain_scores_codex":[0.9991411,0.000469137,0.00005330734,0.0001503003,0.00009119084,0.00009484047],"domain_scores_gemma":[0.9981934,0.0003355743,0.000641854,0.0001579388,0.0001249858,0.0005462577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7785044,0.01569405,0.1400964,0.0002876295,0.001389495,0.0002767056,0.0003271581,0.0008435672,0.009564079,0.00009663506,0.001482307,0.0514375],"study_design_scores_gemma":[0.1691771,0.3234594,0.4963847,0.00007133801,0.001511047,0.0005646248,0.0001667077,0.002879819,0.003086825,0.0001937822,0.002439387,0.0000653195],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985177,0.0004353782,0.00009533446,0.00004870871,0.00001237727,0.0001769564,0.0002990156,0.00001497106,0.0003996131],"genre_scores_gemma":[0.9983968,0.0001075744,0.0001470221,0.0001083626,0.00004868293,0.0001826987,0.0006549209,0.000003380577,0.0003505265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002964745,"threshold_uncertainty_score":0.0156793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04587728601097647,"score_gpt":0.3566049150287874,"score_spread":0.3107276290178109,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}